Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №10 (2025) > Modern technologies in glycemic management and prevention of the diabetes mellitus systemic vascular complications

Modern technologies in glycemic management and prevention of the diabetes mellitus systemic vascular complications

Elena V. Biryukova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Diabetes mellitus (DM) is a disorder, the course of which is associated with the risk of systemic vascular complications that reduce life expectancy. Minimization of the risk of disability and death requires a comprehensive, multifaceted approach to the disease management. In the context of modern therapeutic strategies for management of patients with diabetes the key role is played by self-monitoring of blood glucose (SMBG). The systematic SMBG implementation allows the physician to obtain objective data for evaluation of the applied therapy efficacy and allows the patient to become actively engaged in treatment. The review prepared based on the presentation by Elena V. Biryukova, D. Sci. (Med.), Professor at the Department of Endocrinology and Diabetology, Russian University of Medicine of the Ministry of Healthcare of the Russian Federation, discloses the benefits of SMBG, including its proven efficacy for prevention of hypoglycemic conditions. Regular blood glucose monitoring makes it possible to minimize extreme blood glucose fluctuations and enables the timely adjustment of the therapy prescribed. Special attention is paid to the glucose meter selection criteria, among which the priorities are compliance with the current accuracy standards, convenience and ease of use. Technology improvement not only simplifies the SMBG procedure, but also contributes to the efficacy of glucose-lowering therapy and patient adherence to treatment.
Keywords: diabetes mellitus, hyperglycemia, hypoglycemia, self-monitoring of blood glucose, glucose meters.

About the Author

Elena V. Biryukova
Elena V. Biryukova

References

1. International Diabetes Federation. IDF Diabetes Atlas, 11th ed. 2025. URL: https://diabetesatlas.org
2. Zarich SW. Mechanism by which hyperglycemia plays a role in the setting of acute cardiovascular illness. Rev Cardiovasc Med 2006;7(Suppl 2):S35-43. 
3. Bauters C, Ennezat PV, Tricot O et al; REVE Investigators. Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J 2007 Mar;28(5):546-52. DOI: 10.1093/eurheartj/ehl546 
4. The American Diabetes Association Releases Standards of Care in Diabetes –2025. URL: https://diabetes.org/ 
5. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002 May 15;287(19):2563-9. DOI: 10.1001/jama.287.19.2563 
6. Nathan DM, Cleary PA, Backlund JY et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-53. DOI: 10.1056/NEJMoa052187 
7. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405-12.
8. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321(7258):405-12.
9. Дедов И.И., Шестакова М.В. Сахарный диабет и артериальная гипертензия. М.: МИА, 2006.
Dedov I.I., Shestakova M.V. Diabetes mellitus and arterial hypertension. Moscow: MIA, 2006 (in Russian).
10. SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J 2023;44(28):2544-56. DOI: 10.1093/eurheartj/ehad260 
11. Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes). URL: https://www.mdcalc.com/calc/10510/score2-diabetes
12. Adapted from American Diabetes Association. Diabetes Care 2024;48:S1-S352.
13. Hendrieckx C, Hagger V, Jenkins A et al. Severe hypoglycemia, impaired awareness of hypoglycemia, and self-monitoring in adults with type 1 diabetes: Results from Diabetes MILES-Australia. J Diabetes Complications 2017;31(3):577-82. DOI: 10.1016/j.jdiacomp.2016.11.013 
14. Little SA, Leelarathna L, Barendse SM et al. Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention. Diabetes Metab Res Rev 2014;30(3):175-90. DOI: 10.1002/dmrr.2492 
15. Patton SR. Adherence to glycemic monitoring in diabetes. J Diabetes Sci Technol 2015 May;9(3):668-75. DOI: 10.1177/193229681456 7709
16. Self-monitoring of blood glucose. URL: https://healthcare-in-europe.com/en/news/self-monitoring-of-blood-glucose.html
17. Fisher WA, Kohut T, Schachner H, Stenger P. Understanding self-monitoring of blood glucose among individuals with type 1 and type 2 diabetes: an information-motivation-behavioral skills analysis. Diabetes Educ 2011;37(1):85-94. DOI: 10.1177/0145721710391479 
18. Pardo S et al. Changes in Blood Glucose Excursions After at Least 180 Days Real-world Use of a New Smartphone Application for Blood Glucose Monitoring. Poster presented at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); February 20–23, 2019; Berlin, Germany. Diabetes Technol Ther. 2019;21(Suppl 1):A-112.
19. Stuhr A, Pardo S. Impact of Real-World Use of the CONTOUR®DIABETES App on Glycemic Control and Testing Frequency. 2018 Diabetes Technology Meeting Abstracts.
20. Grady M, Katz LB, Levy BL. Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients With Diabetes in Comparison to Blood Glucose Meters Without Color 
(ACCENTS Study). J Diabetes Sci Technol 2018;12(6):1211-9. DOI: 10.1177/1932296818775755 
21. Grady M, Warren G, Levy BL, Katz LB. Interactive Exposure With a Blood Glucose Monitor With a Novel Glucose Color Range Indicator Is Associated With Improved Glucose Range Interpretation and Awareness in Patients With Type 2 Diabetes. J Diabetes Sci Technol 2015;9(4):841-8. DOI: 10.1177/1932296815569882 
22. Klaff L, Shelat P, Zondorak D et al. Accuracy and User Performance of a New Blood Glucose Monitoring System. J Diabetes Sci Technol 2021;15(6):1382-9. DOI: 10.1177/1932296820974348
23. International Organization for Standardization. In vitro diagnostic test systems - requirements for Blood glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197). Geneva, Switzerland: International Organization for Standardization, 2013.
24. Stedman M, Rea R, Duff CJ et al. Self-Reported Views on Managing Type 1 Diabetes Mellitus. J Diabetes Sci Technol 2021 Jan;15(1):198-200. DOI: 10.1177/1932296820937771
25. Boettcher C, Dost A, Wudy SA et al; German/Austrian Diabetes Prospective Documentation Initiative. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther 2015;17(4):275-82. DOI: 10.1089/dia.2014.0262
26. Campos-Náñez E, Breton MD. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study. J Diabetes Sci Technol 2017;11(6):1196-206. DOI: 10.1177/1932296817710476 
27. Smartson online survey, Sweden 2017. 352 respondents: People with type 1 and type 2 diabetes, over 18 years old, who tested at least 4–7 times a day. Participants received free meter and tests strips. Survey funded by Ascensia Diabetes Care.
28. Richardson J et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the virtual 20th Annual Diabetes Technology Meeting (DTM). 2020 Diabetes Technology Meeting Abstracts. 2020;15(2):A62.

For citation:Modern technologies in glycemic management and prevention of the diabetes mellitus systemic vascular complications. Clinical review for general practice. 2025; 6 (10): 55–59 (In Russ.). DOI: 10.47407/kr2025.6.10.00693


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru